Navigation Links
OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences
Date:9/3/2009

BOTHELL, WA and VANCOUVER, Sept. 3 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the company will webcast presentations at the following investor conferences:

    -   Rodman & Renshaw 11th Annual Healthcare Conference on Thursday,
        September 10, 2009 at 12:30 p.m. Eastern Time in the Fahnestock Salon
        at the New York Palace Hotel in New York City.

    -   Thomas Weisel Partners Healthcare Conference on Friday, September 11,
        2009 at 10:20 a.m. Eastern Time in the Stuart Room at the Four
        Seasons Hotel in Boston.

    -   BioCentury NewsMakers in the Biotech Industry Conference on
        Wednesday, September 16, 2009 at 2:30 p.m. Eastern Time in room
        304/305 at the Millennium Broadway Hotel & Conference Center in New
        York City.

Access to a live webcast of each of the presentations will be available on the Events Presentation section of the Investor Relations page on the company Web site at www.oncogenex.com. A replay of each webcast will be available for 30 days following the event.

About OncoGenex

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the lead candidate that has completed five Phase 2 clinical studies in prostate, lung and breast cancers, is designed to inhibit the production of a specific protein associated with treatment resistance; OGX-427 is in Phase 1 clinical develo
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
2. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
3. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
4. OncoGenex increases economic interest in lead cancer drug OGX-011
5. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
8. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
9. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... have developed a unique nanoscale device that for ... The discovery could have major implications for creating ... and communication. , The research paper by University ... Mo Li and his graduate student Huan Li ... the October issue of Nature Nanotechnology . ...
(Date:9/22/2014)... , Sept. 22, 2014 US demand to ... for specialty biocides is forecast to rise 3.9 percent ... terms, demand is projected to increase 1.3 percent per ... A strong rebound in construction expenditures will support demand ... coatings markets, while growth in consumer spending and manufacturing ...
(Date:9/22/2014)... Research and Markets has announced ... Cellulose Industry Report 2014" report to their offering. ... Industry Report 2014 is a professional and in-depth study ... industry with a focus on the Chinese situation. ... industry including definitions, classifications, applications and industry chain structure. ...
(Date:9/22/2014)... September 22, 2014 FierceBiotech today announced ... held biotechnology companies of 2014. FierceBiotech editors John ... selecting this year’s winners. Those selected are identified ... in the industry. , "It's always a ... of Fierce 15 companies," said Carroll. "This year in ...
Breaking Biology Technology:Engineers show light can play seesaw at the nanoscale 2US Biocides Market 2US Biocides Market 3Global and Chinese Microcrystalline Cellulose Industry Report 2014 2FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2
... Aug. 23 AspenBio Pharma,Inc. (OTC Bulletin Board: APNB) ... drugs and diagnostics for animals and,humans, today announced its ... Markets Stock Exchange has been approved. The company ... the NASDAQ CM commencing with the open of trading ...
... ImmuneRegen,s Homspera(TM) Submitted to RFI, ,Therapeutic ... and B Threat Agents, SCOTTSDALE, Ariz., Aug. ... Inc. a wholly,owned subsidiary of IR BioSciences Holdings, ... has recently responded to a Request for,Information (RFI) ...
... Aug. 22 Biodel, Inc. (Nasdaq:,BIOD) today ... to its,Scientific Advisory Board (SAB). Dr. ... of Research,and Development at Kos Pharmaceuticals, where ... Kos was acquired by Abbott Laboratories. Dr.,Rosskamp,s ...
Cached Biology Technology:AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY' 2AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY' 3AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY' 4ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information 2ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information 3Ralf Rosskamp, M.D. Joins Biodel's Scientific Advisory Board 2Ralf Rosskamp, M.D. Joins Biodel's Scientific Advisory Board 3
(Date:9/21/2014)... On the eve of United Nations General Assembly events ... of mothers, newborns and children, Grand Challenges Canada, funded ... in grants for 22 bold ideas to address this ... A program for Bangladeshi mothers working in garment ... thereby improving infant nutrition, reducing absenteeism due to child ...
(Date:9/21/2014)... strains of bacteria have emerged that resist even the ... forms of tuberculosis and staphylococcus, infect more than 2 ... the urgent need for new treatments, scientists have discovered ... decade. , MIT engineers have now turned a powerful ... that can disable any target gene, they have shown ...
(Date:9/19/2014)... from several Harvard University labs in collaboration with ... researchers with the intellectual raw materials needed to ... flexible materials. , With the advent of low-cost ... manufacturing technology, soft robotics is emerging as an ... rigid robot design, but working with pliable materials, ...
Breaking Biology News(10 mins):Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 2Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 3Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 4Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 5Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 6Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 7Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 8Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 9Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 10Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 11Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 12Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 13Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 14Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 15Battling superbugs 2Battling superbugs 3Battling superbugs 4Soft robotics 'toolkit' features everything a robot-maker needs 2
... one day be synthesised using biotechnology, following CSIRO,s discovery ... beetles with their potent predator defence system., CSIRO researchers, ... of the gene identification breakthrough and potential applications recently ... the first time, our team has been able to ...
... crocodiles and alligators are much prized by the fashion ... animals. Some are from endangered species and according to ... way to distinguish legitimate hides from poached skins is ... pigmented bumps that pepper crocodiles, bodies. Adding that the ...
... following 110,645 workers who helped clean up after the ... Soviet territory of Ukraine shows that the workers share ... may help scientists better define cancer risk associated with ... such as computed tomography scans and other sources. ...
Cached Biology News:Gene find turns soldier beetle defence into biotech opportunity 2Tactile croc jaws more sensitive than human fingertips 2Tactile croc jaws more sensitive than human fingertips 3Chernobyl cleanup workers had significantly increased risk of leukemia 2Chernobyl cleanup workers had significantly increased risk of leukemia 3
MBS 384 well satellite block unit with height adjusting heated lid, 384 well block holds 1 x 0.04 ml 384 well plate...
Wellpro 96 an automated liquid handling system for 96-well plates that quickly and accurately prepares large quantities of serial dilutions. The Wellpro also performs plate to plate transfers using ...
Multidrop DW is a high-speed automated dispenser for Deep Well plates, 1.1 ml test tubes and 96-well plates. Designed for accuracy and precision, the Multidrop DW dispenses up to eight different reag...
...
Biology Products: